News

There 's one bladder cancer symptom that commonly triggers a visit to the doctor. One survivor shares the sign that helped ...
The U.S. FDA has approved Johnson & Johnson's INLEXZO (gemcitabine intravesical system) for adults with BCG-unresponsive ...
Intravesical cretostimogene is administered in combination with n-dodecyl-β-D-maltoside (DDM), an excipient that enhances adenoviral delivery, for 6 weekly doses during the induction phase, followed ...